Texas Heart Institute at St. Luke's Episcopal Hospital is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The Texas Heart Institute designates this educational activity for a maximum of 3.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Estimated Study Time
The estimated time to complete this activity, including review of the materials and completion of the course assessment is 3-1/4 hours.
If you previously completed and received credit for the live CME-sponsored symposium entitled Risk, Diagnosis and Treatment of Cardiovascular Disease in Women, on September 11, 2010, please note that you will not receive credit for completing this activity. Participants who take part in an identical activity, even in order to validate learning or to clarify specific topics, cannot claim, nor will the Texas Heart Institute award, duplicate credit for the activity.
Term of Approval
June 24, 2011 through June 24, 2014. Continuation of CME credit from June 24, 2014 depends upon a thorough review of the content for currency and accuracy.
In June 2011, this continuing medical education activity was reviewed for currency and accuracy of content by Patrick J. Hogan, MD, FACC, Director Learning Resource Center and Co-Chairman, Medical Education Committee, Texas Heart Institute, Houston, TX.
Disclosure of Relationships
It is the intent of the Texas Heart Institute to ensure that its educational mission and its continuing medical activities in particular, should not be influenced by the special interests of individuals associated with its program.
In accordance with the guidelines of the Accreditation Council for Continuing Medical Education, faculty members have disclosed their relationships with either the manufacturers of commercial products discussed, or the corporate organizations offering educational grants for the live continuing medical education activity.
Ann Smith Barnes, MD has nothing to disclose relevant to this program.
Eric Boerwinkle, PhD has nothing to disclose relevant to this program.
Roberta Bogaev, MD has nothing to disclose relevant to this program.
Stephanie Coulter, MD has nothing to disclose relevant to this program.
Wayne J. Franklin, MD has nothing to disclose relevant to this program.
Eduardo Hernandez-Vila, MD has nothing to disclose relevant to this program.
Salim Virani, MD receives research grants from Merck &Co, Inc., NIH, VA and NFL. He is on the speakers' bureau of Abbott Laboratories.
In addition, peer reviewer, Patrick J. Hogan, MD has nothing to disclose relevant to this program.